The reports were created using data from the GOED Clinical Study Database tracking human clinical studies on EPA and DHA omega-3 fatty acids.
Two new reports from omega-3 association the Global Organization for EPA and DHA Omega-3s (GOED; Salt Lake City, UT) report on the clinical research landscape examining the link between EPA and DHA omega-3 fatty acids and skin health conditions dermatitis and psoriasis. The reports were created using data from the GOED Clinical Study Database tracking human clinical studies on EPA and DHA omega-3 fatty acids.
“Both reports offer valuable insights, including the background of the conditions, the number and type of articles published, commonly found biomarkers, key influencers in the field, and suggested next research steps,” GOED’s press release states. On its website, it further adds, “These two skin conditions”—dermatitis and psoriasis—“are stand-ins for common omega-3 skin health marketing claims like ‘promotes glowing, healthy, smooth skin,’ which don’t match any scientifically recognized clinical outcomes.”
GOED’s Clinical Study Database captures data on more than 4,500 human clinical studies on EPA and DHA omega-3s.